{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:24:53Z","timestamp":1781753093151,"version":"3.54.5"},"reference-count":16,"publisher":"Japan Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1507\/endocrj.ej20-0753","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T22:07:52Z","timestamp":1612562872000},"page":"649-654","source":"Crossref","is-referenced-by-count":2,"title":["Favorable outcomes of papillary thyroid microcarcinoma concurrent with Graves\u2019 disease after radioactive iodine therapy"],"prefix":"10.1507","volume":"68","author":[{"given":"Eijun","family":"Nishihara","sequence":"first","affiliation":[{"name":"Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Kudo","sequence":"additional","affiliation":[{"name":"Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Ito","sequence":"additional","affiliation":[{"name":"Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Fukata","sequence":"additional","affiliation":[{"name":"Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsushige","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Akamizu","sequence":"additional","affiliation":[{"name":"Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Filetti S, Belfiore A, Amir SM, Daniels GH, Ippolito O, et al. (1988) The role of thyroid-stimulating antibodies of Graves\u2019 disease in differentiated thyroid cancer. N Engl J Med 318: 753\u2013759.","DOI":"10.1056\/NEJM198803243181206"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Stocker DJ, Foster SS, Solomon BL, Shriver CD, Burch HB (2002) Thyroid cancer yield in patients with Graves\u2019 disease selected for surgery on the basis of cold scintiscan defects. Thyroid 12: 305\u2013311.","DOI":"10.1089\/10507250252949432"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Kikuchi S, Noguchi S, Yamashita H, Uchino S, Kawamoto H (2006) Prognosis of small thyroid cancer in patients with Graves\u2019 disease. Br J Surg 93: 434\u2013439.","DOI":"10.1002\/bjs.5279"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Miyauchi A, Ito Y (2019) Conservative surveillance management of low-risk papillary thyroid microcarcinoma. Endocrinol Metab Clin North Am 48: 215\u2013226.","DOI":"10.1016\/j.ecl.2018.10.007"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5 Sugitani I, Ito Y, Miyauchi A, Imai T, Suzuki S (2019) Active surveillance <i>versus<\/i> immediate surgery: questionnaire survey on the current treatment strategy for adult patients with low-risk papillary thyroid microcarcinoma in Japan. Thyroid 29: 1563\u20131571.","DOI":"10.1089\/thy.2019.0211"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6 Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, et al. (2014) Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 24: 27\u201334.","DOI":"10.1089\/thy.2013.0367"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Sugitani I, Ito Y, Takeuchi D, Nakayama H, Masaki C, et al. (2020) Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery task force on management for papillary thyroid microcarcinoma. Thyroid <i>(in press)<\/i>","DOI":"10.1089\/thy.2020.0330"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kasuga Y, Sugenoya A, Kobayashi S, Masuda H, Iida F (1993) The outcome of patients with thyroid carcinoma and Graves\u2019 disease. Surg Today 23: 9\u201312.","DOI":"10.1007\/BF00308993"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Hales IB, McElduff A, Crummer P, Clifton-Bligh P, Delbridge L, et al. (1992) Does Graves\u2019 disease or thyrotoxicosis affect the prognosis of thyroid cancer. J Clin Endocrinol Metab 75: 886\u2013889.","DOI":"10.1210\/jcem.75.3.1517381"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10 Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, et al. (2016) 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26: 1343\u20131421.","DOI":"10.1089\/thy.2016.0229"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11 Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, et al. (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26: 1\u2013133.","DOI":"10.1089\/thy.2015.0020"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Kahaly GJ, Bartalena L, Hegedus L, Leenhardt L, Poppe K, et al. (2018) 2018 European Thyroid Association guideline for the management of Graves\u2019 hyperthyroidism. Eur Thyroid J 7: 167\u2013186.","DOI":"10.1159\/000490384"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13 Miyauchi A, Kudo T, Ito Y, Oda H, Yamamoto M, et al. (2019) Natural history of papillary thyroid microcarcinoma: kinetic analyses on tumor volume during active surveillance and before presentation. Surgery 165: 25\u201330.","DOI":"10.1016\/j.surg.2018.07.045"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Ito Y, Miyauchi A, Kudo T, Higashiyama T, Masuoka H, et al. (2019) Kinetic analysis of growth activity in enlarging papillary thyroid microcarcinomas. Thyroid 29: 1765\u20131773.","DOI":"10.1089\/thy.2019.0396"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15 Nakamura H, Hirokawa M, Ota H, Kihara M, Miya A, et al. (2015) Is an increase in thyroid nodule volume a risk factor for malignancy? Thyroid 25: 804\u2013811.","DOI":"10.1089\/thy.2014.0567"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Kim WB, Han SM, Kim TY, Nam-Goong IS, Gong G, et al. (2004) Ultrasonographic screening for detection of thyroid cancer in patients with Graves\u2019 disease. Clin Endocrinol (Oxf) 60: 719\u2013725.","DOI":"10.1111\/j.1365-2265.2004.02043.x"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/6\/68_EJ20-0753\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T04:43:44Z","timestamp":1625287424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/6\/68_EJ20-0753\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0753","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}